National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2018 (No. 3) (PB 113 of 2018) (Cth)

PB 113 of 2018

National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2018 (No. 3)

National Health Act 1953

___________________________________________________________________________

I, NATASHA PLOENGES, Assistant Secretary (Acting), Pharmacy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Amendment Instrument under subsection 100(2) of the National Health Act 1953.

Dated   19 December 2018

NATASHA PLOENGES

Assistant Secretary (Acting)

Pharmacy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This instrument is the National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2018 (No. 3).

(2)This instrument may also be cited as PB 113 of 2018.

1. Commencement

This instrument commences on 1 January 2019.

1. Amendment of National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015)

Schedule 1 amends the National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015).

Schedule 1       Amendments

1. Schedule 1, Part 1, entry for Somatropin

omit:

Injection 12 mg (36 i.u.) in 1 mL cartridge (with preservative) Injection Genotropin D(100)

1. Schedule 1, Part 1, entry for Somatropin in the form Solution for injection 5 mg (15 i.u.) in 1.5 mL cartridge (with preservative)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

Scitropin A D(100)

1. Schedule 1, Part 2, entry for Somatropin

omit:

Injection 12 mg (36 i.u.) in 1 mL cartridge (with preservative) Injection Genotropin D(100)